These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11258166)

  • 1. Thrombin inhibitor approved for anticoagulation during angioplasty.
    Lieder TR
    Am J Health Syst Pharm; 2001 Mar; 58(5):363. PubMed ID: 11258166
    [No Abstract]   [Full Text] [Related]  

  • 2. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 3. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor.
    Maraganore JM
    Adv Exp Med Biol; 1993; 340():227-36. PubMed ID: 8154339
    [No Abstract]   [Full Text] [Related]  

  • 5. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin: a review.
    Warkentin TE; Koster A
    Expert Opin Pharmacother; 2005 Jul; 6(8):1349-71. PubMed ID: 16013985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct thrombin inhibitors in acute coronary syndromes.
    Jang IK
    Lancet; 2002 Aug; 360(9331):491-2; author reply 492. PubMed ID: 12241752
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct thrombin inhibitors (part 2 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Feb; 17(2):85-91. PubMed ID: 15687531
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin and hirudin analogues as new anticoagulant agents.
    Pineo GF; Hull RD
    Curr Opin Hematol; 1995 Sep; 2(5):380-5. PubMed ID: 9372023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin: a new generation antithrombotic drug.
    Scatena R
    Expert Opin Investig Drugs; 2000 May; 9(5):1119-27. PubMed ID: 11060732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of conjunctive anticoagulant strategies in thrombolysis.
    Kleiman NS
    Coron Artery Dis; 1996 Jul; 7(7):508-15. PubMed ID: 8913678
    [No Abstract]   [Full Text] [Related]  

  • 13. [Refractory angina pectoris: clinical diagnosis and treatment].
    Huang YL
    Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):333-4. PubMed ID: 7994638
    [No Abstract]   [Full Text] [Related]  

  • 14. Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosis.
    Reid T; Alving BM
    Am J Hematol; 1994 Apr; 45(4):352-3. PubMed ID: 8192819
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring of bivalirudin anticoagulation during and after cardiopulmonary bypass using an ecarin-activated TEG system.
    Koster A; Buz S; Krabatsch T; Dehmel F; Hetzer R; Kuppe H; Dyke C
    J Card Surg; 2008; 23(4):321-3. PubMed ID: 18482390
    [No Abstract]   [Full Text] [Related]  

  • 16. New developments in parenteral anticoagulation for arterial and venous thromboembolism.
    van Es N; Bleker SM; Büller HR; Coppens M
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):203-13. PubMed ID: 23953908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Publication policy, informed consent, and the randomized clinical trial.
    Califf RM
    Am Heart J; 2002 Feb; 143(2):187-8. PubMed ID: 11835017
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct thrombin inhibitors for non-ST-segment elevation acute coronary syndromes: what, when, and where?
    Lincoff AM
    Am Heart J; 2003 Oct; 146(4 Suppl):S23-30. PubMed ID: 14564303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current anticoagulation options in percutaneous intervention: designing patient-specific strategies.
    French MH; Faxon DP
    Rev Cardiovasc Med; 2002; 3(4):176-82. PubMed ID: 12556751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and clinical use of bivalirudin.
    Sciulli TM; Mauro VF
    Ann Pharmacother; 2002 Jun; 36(6):1028-41. PubMed ID: 12022907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.